Free Trial

State Street Corp Acquires 64,081 Shares of Arteris, Inc. (NASDAQ:AIP)

Arteris logo with Computer and Technology background

State Street Corp lifted its holdings in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) by 18.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 410,578 shares of the company's stock after buying an additional 64,081 shares during the period. State Street Corp owned about 1.02% of Arteris worth $3,170,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of AIP. US Bancorp DE acquired a new position in shares of Arteris during the third quarter worth $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris in the 2nd quarter valued at approximately $86,000. Algert Global LLC acquired a new stake in Arteris during the 2nd quarter worth approximately $115,000. MetLife Investment Management LLC grew its holdings in Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in Arteris in the 3rd quarter valued at approximately $226,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Arteris Stock Down 1.5 %

Arteris stock traded down $0.16 during midday trading on Tuesday, hitting $10.19. 165,598 shares of the stock were exchanged, compared to its average volume of 169,888. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $409.40 million, a price-to-earnings ratio of -10.61 and a beta of 1.25. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $10.69. The business's 50-day moving average price is $8.56 and its 200-day moving average price is $7.97.

Analyst Ratings Changes

Separately, Rosenblatt Securities restated a "buy" rating and issued a $15.00 price target on shares of Arteris in a research report on Wednesday, November 6th.

Get Our Latest Research Report on Arteris

Insider Transactions at Arteris

In other news, CEO K Charles Janac sold 60,584 shares of Arteris stock in a transaction dated Thursday, December 26th. The shares were sold at an average price of $10.42, for a total value of $631,285.28. Following the completion of the transaction, the chief executive officer now owns 10,134,541 shares in the company, valued at $105,601,917.22. This trade represents a 0.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Saiyed Atiq Raza sold 41,439 shares of the business's stock in a transaction on Thursday, December 26th. The shares were sold at an average price of $10.37, for a total transaction of $429,722.43. Following the sale, the director now directly owns 690,121 shares in the company, valued at $7,156,554.77. The trade was a 5.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 216,086 shares of company stock worth $2,080,080 in the last ninety days. Company insiders own 33.70% of the company's stock.

Arteris Company Profile

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

→ Buy this Stock before Trump Takes Office! (From Behind the Markets) (Ad)

Should you invest $1,000 in Arteris right now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way
Analysts Predict Big Gains for These 3 Cybersecurity Leaders

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines